ACQUIRED RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE BY PHENOTYPIC PLASTICITY OF MELANOMA

被引:0
|
作者
Robitschek, Emily [1 ]
Mehta, Arnav [2 ]
Lin, Jia-Ren [3 ]
Frederick, Dennie [4 ]
Shi, Alvin [5 ]
Larque, Ana [6 ]
Miao, Benchun [2 ]
Raghavan, Rumya [7 ]
Sharova, Tatyana [2 ]
Shin, John [2 ]
Kellis, Manolis [5 ]
Hacohen, Nir [4 ]
Flaherty, Keith [2 ]
Boland, Genevieve [2 ]
Chebib, Ivan [2 ]
Liu, David [1 ]
Sullivan, Ryan [2 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[5] MIT, Boston, MA USA
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Broad Inst Harvard & MIT, Cambridge, MA USA
关键词
D O I
10.1136/jitc-2022-SITC2022.0916
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
916
引用
收藏
页码:A955 / A955
页数:1
相关论文
共 50 条
  • [1] Acquired resistance to immune checkpoint inhibition by melanoma phenotypic transformation
    Mehta, Arnav
    Liu, David
    Shi, Alvin
    Frederick, Dennie T.
    Ho, Li-Lun
    Larque, Ana B.
    Miao, Benchun
    Raghavan, Rumya S.
    Sharova, Tatyana
    Shin, John H.
    Rinaldi, Nicola
    Chebib, Ivan A.
    Kellis, Manolis
    Van Allen, Eliezer
    Hacohen, Nir
    Flaherty, Keith T.
    Boland, Genevieve M.
    Sullivan, Ryan J.
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Acquired Resistance to Immune Checkpoint Blockade Therapies
    Zhao, Xianda
    Wangmo, Dechen
    Robertson, Matthew
    Subramanian, Subbaya
    CANCERS, 2020, 12 (05)
  • [3] Molecular patterns of resistance to immune checkpoint blockade in melanoma
    Lauss, Martin
    Phung, Bengt
    Borch, Troels Holz
    Harbst, Katja
    Kaminska, Kamila
    Ebbesson, Anna
    Hedenfalk, Ingrid
    Yuan, Joan
    Nielsen, Kari
    Ingvar, Christian
    Carneiro, Ana
    Isaksson, Karolin
    Pietras, Kristian
    Svane, Inge Marie
    Donia, Marco
    Jonsson, Goran
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [4] The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
    Lim, Su Yin
    Shklovskaya, Elena
    Lee, Jenny H.
    Pedersen, Bernadette
    Stewart, Ashleigh
    Ming, Zizhen
    Irvine, Mal
    Shivalingam, Brindha
    Saw, Robyn P. M.
    Menzies, Alexander M.
    Carlino, Matteo S.
    Scolyer, Richard A.
    Long, Georgina V.
    Rizos, Helen
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [5] The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
    Su Yin Lim
    Elena Shklovskaya
    Jenny H. Lee
    Bernadette Pedersen
    Ashleigh Stewart
    Zizhen Ming
    Mal Irvine
    Brindha Shivalingam
    Robyn P. M. Saw
    Alexander M. Menzies
    Matteo S. Carlino
    Richard A. Scolyer
    Georgina V. Long
    Helen Rizos
    Nature Communications, 14
  • [6] Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Gide, Tuba N.
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2018, 24 (06) : 1260 - 1270
  • [7] Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer
    Bellone, Matteo
    Elia, Angela Rita
    CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 36 : 17 - 24
  • [8] Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
    Douglas B. Fox
    Richard Y. Ebright
    Xin Hong
    Hunter C. Russell
    Hongshan Guo
    Thomas J. LaSalle
    Ben S. Wittner
    Nicolas Poux
    Joanna A. Vuille
    Mehmet Toner
    Nir Hacohen
    Genevieve M. Boland
    Debattama R. Sen
    Ryan J. Sullivan
    Shyamala Maheswaran
    Daniel A. Haber
    npj Precision Oncology, 7
  • [9] Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
    Fox, Douglas B.
    Ebright, Richard Y.
    Hong, Xin
    Russell, Hunter C.
    Guo, Hongshan
    LaSalle, Thomas J.
    Wittner, Ben S.
    Poux, Nicolas
    Vuille, Joanna A.
    Toner, Mehmet
    Hacohen, Nir
    Boland, Genevieve M.
    Sen, Debattama R.
    Sullivan, Ryan J.
    Maheswaran, Shyamala
    Haber, Daniel A.
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [10] MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma
    de Azevedo, Ricardo A.
    Shoshan, Einav
    Whang, Shanzhi
    Markel, Gal
    Jaiswal, Ashvin R.
    Liu, Arthur
    Curran, Michael A.
    Travassos, Luiz R.
    Bar-Eli, Menashe
    ONCOIMMUNOLOGY, 2020, 9 (01):